CRBN and Miyoshi myopathy: More particularly, in MM cell lines, CRBN mRNA expression was examined after continuous exposure for 6 months to lenalidomide 1 mM, as well as in cultures treated sequentially with 1 mM for 2 months followed by 10 mM lenalidomide for 4 months.